- Report
- June 2026
- 196 Pages
Global
From €3218EUR$3,545USD£2,772GBP
€3576EUR$3,939USD£3,080GBP
- Report
- January 2026
- 185 Pages
Global
From €4085EUR$4,500USD£3,519GBP
- Report
- January 2026
- 185 Pages
Global
From €4085EUR$4,500USD£3,519GBP
- Report
- January 2026
- 180 Pages
Global
From €4085EUR$4,500USD£3,519GBP
- Report
- July 2025
- 350 Pages
Global
From €4492EUR$4,949USD£3,870GBP
- Report
- April 2026
- 144 Pages
Global
From €3630EUR$3,999USD£3,127GBP
- Report
- May 2026
- 304 Pages
Global
From €2269EUR$2,500USD£1,955GBP
- Report
- April 2026
- 160 Pages
Global
From €3767EUR$4,150USD£3,245GBP
- Report
- November 2025
- 160 Pages
Global
From €3586EUR$3,950USD£3,089GBP
- Report
- October 2025
- 160 Pages
Global
From €3586EUR$3,950USD£3,089GBP
- Report
- August 2025
- 150 Pages
Global
From €3495EUR$3,850USD£3,011GBP
- Report
- June 2026
- 179 Pages
Global
From €5310EUR$5,850USD£4,575GBP
- Report
- October 2023
- 385 Pages
Global
From €4493EUR$4,950USD£3,871GBP
- Report
- January 2024
- 485 Pages
Global
From €4221EUR$4,650USD£3,636GBP
- Report
- November 2024
- 120 Pages
Global
From €5401EUR$5,950USD£4,653GBP
- Report
- May 2023
- 110 Pages
Global
From €5401EUR$5,950USD£4,653GBP
- Report
- February 2023
- 180 Pages
Global
From €5401EUR$5,950USD£4,653GBP
From €4493EUR$4,950USD£3,871GBP
- Report
- December 2024
- 200 Pages
Global
From €3404EUR$3,750USD£2,932GBP
- Report
- April 2024
- 447 Pages
Global
From €3812EUR$4,200USD£3,284GBP

Polyclonal antibodies are a type of immune disorder drug used to treat a variety of conditions, including autoimmune diseases, allergies, and cancer. These drugs are made up of a mixture of antibodies that are produced by the body in response to a foreign substance, such as a virus or bacteria. They work by targeting and neutralizing the foreign substance, thus preventing it from causing further damage. Polyclonal antibodies can be administered intravenously, intramuscularly, or subcutaneously.
Polyclonal antibodies are used to treat a variety of conditions, including rheumatoid arthritis, multiple sclerosis, Crohn's disease, and psoriasis. They are also used to treat certain types of cancer, such as lymphoma and leukemia. In addition, polyclonal antibodies are used to treat allergies, such as hay fever and asthma.
The polyclonal antibodies market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more